The following is a summary of the Neogen Corporation (NEOG) Q4 2024 Earnings Call Transcript:

Financial Performance:

• Neogen Corporation reported Q4 revenues of $237 million, with a core revenue growth of 2%. Adjusted EBITDA for the quarter was $53 million, reflecting a year-over-year decline.

• Gross margin was 47.9%, down from 50.9% in the previous year due to costs related to stabilizing distribution and logistics operations.

• Adjusted net income and adjusted earnings per share were $22 million and $0.10, respectively, both decreasing from the previous year.

Business Progress:

• Successfully integrated the former 3M sample handling product lines and ramped up to full production levels.

• Enhanced shipping performance and commercial focus on demand generation.

• Launched an automated Petrifilm reader, targeting high-throughput labs, and integrated with existing workflows to improve efficiency.

• Achieved designation of the Neogen Molecular Detection System by the USDA as the primary screening method for Salmonella and Listeria in various food categories.

Opportunities:

• Expecting a mid-single-digit range growth in core revenue for FY 2025, driven by improvements in the food safety and animal safety sectors and new product innovations like the automated Petrifilm reader.

Risks:

• Persistent challenges in food production volumes due to market and economic conditions, impacting growth. Continued reliance on resolving distribution inefficiencies and optimizing logistics operations to meet demand.

More details: Neogen IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.